ClinConnect ClinConnect Logo
Search / Trial NCT05636384

SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Nov 23, 2022

Trial Information

Current as of August 27, 2025

Recruiting

Keywords

ClinConnect Summary

The STAHR-cancer trial is studying how home-based care can help patients with advanced cancer avoid unplanned hospital visits over a period of six months. This care includes providing education to patients and their family caregivers, as well as having specialized medical staff visit patients at home and check in on their health regularly. The goal is to improve the quality of life for those with advanced cancer and support them in staying at home.

To be eligible for this trial, both the patient and their family caregiver must meet certain criteria. Patients must have advanced-stage solid cancer, be receiving or planning to receive treatment, and wish to stay at home. Family caregivers should live with the patient or visit them frequently and be able to communicate easily with medical staff. Participants can expect to receive personalized support and care while contributing to important research that may improve home care for cancer patients in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Both the patient and their family caregiver must meet the criteria to be considered for this research.
  • 1. Patient
  • 1. A person who has an advanced-stage solid cancer diagnosis (ICD-10 code C00-C70); A person who is receiving or planning to receive cancer treatment
  • 2. A person who meets one of the following conditions
  • 1. Has been evaluated as having ECOG performance status 2
  • 2. Has been evaluated as having ECOG performance status 1 and is over 70 years of age
  • 3. A person who wishes to stay at home
  • 4. A person whose family caregiver resides at home
  • 5. A person who wishes to participate in the research
  • 2. Family Caregiver
  • 1. A family\* member of the patient
  • \* Family: refers to the patient's spouse (including a common-law partner), descendants and their spouses up to the second degree, siblings and their spouses, and relatives and their spouses up to the eighth degree.
  • 2. A person who meets one of the following conditions:
  • 1. Lives with the patient (patient's household member)
  • 2. Does not live with the patient, but visits the patient's home more than three times a week
  • 3. A person who wants the patient to stay at home
  • 4. A person who can communicate easily with medical staff
  • 5. A person who wishes to participate in the research
  • Exclusion Criteria:
  • If either the patient or the family caregiver meets any one of these criteria, they are excluded from the study.
  • 1. Patient
  • 1. A person who cannot speak, hear, or read Korean
  • 2. A person who is judged by a medical doctor to be unable to take part in this research due to extremely poor health
  • 3. A person residing outside the range that can be visited by the respective medical institution (the conditions for distance are to be specified by each medical institution)\*
  • \* This condition is not applicable for the control group.
  • 4. A person who has used hospital- or home-type hospice and palliative care services
  • 5. A person who is under the age of 19
  • 2. Family Caregiver
  • 1. A person who cannot speak, hear, or read Korean
  • 2. A person who is judged by a medical doctor to be unable to take part in this research due to extremely poor health
  • 3. A person under the age of 19

About Seoul National University Hospital

Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.

Locations

Seoul, , Korea, Republic Of

Seoul, , Korea, Republic Of

Seoul, , Korea, Republic Of

Seongnam Si, Gyeonggi Do, Korea, Republic Of

Goyang Si, Gyeonggi Do, Korea, Republic Of

Seoul, , Korea, Republic Of

Seongnam Si, Gyeonggi Do, Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Belong Cho, MD, MPH, PhD

Principal Investigator

Seoul National University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials